Nurix Therapeutics, Inc. (NRIX)
Nurix Therapeutics, Inc. filed 25 Form 4 statements naming a Rule 10b5-1 trading plan in the 2025 filing year, by 3 reporting owners, covering 32 transactions and 229,044 shares. None carries the SEC's AFF10B5ONE flag; all 25 name a plan in a footnote. 8 results prints are on file in the same window.
What stands out
- The most recent filing on file, dated 2026-09-02, came 1 day after the one before it (2026-09-01) and reports 4 transactions against 3 in the filing before it.
- The sales it reports total 5,787 shares, 4,335 more than the 1,452 in the filing before it.
- Its 25 plan statements rank 243rd of the 483 companies the register carries in Delaware, its state of incorporation.
- Of the 10 companies the register lists beside it in its industry, 3 have more plan statements on file than it and 7 have fewer.
- Its 25 filings on file run from 2025-01-02 to 2026-09-02, and state no plan adoption date.
Trades in Nurix Therapeutics, Inc. 32
- Ring Christine — 2025-01-02 · S · 5,760 shares
- Ring Christine — 2025-01-31 · S · 5,660 shares
- Ring Christine — 2025-01-31 · S · 100 shares
- van Houte Hans — 2025-03-03 · S · 5,125 shares
- van Houte Hans — 2025-03-03 · S · 700 shares
- van Houte Hans — 2025-05-02 · S · 6,198 shares
- van Houte Hans — 2025-08-01 · S · 5,402 shares
- van Houte Hans — 2025-11-03 · S · 6,284 shares
- Ring Christine — 2025-11-24 · S · 37,600 shares
- Ring Christine — 2025-12-18 · S · 3,560 shares
- Ring Christine — 2025-12-18 · S · 200 shares
- Ring Christine — 2026-01-20 · S · 3,760 shares
Adoption dates in Nurix Therapeutics, Inc. 0
Results prints in Nurix Therapeutics, Inc. 8
- 2025-01-13
- 2025-01-28
- 2025-04-08
- 2025-07-09
- 2025-10-09
- 2026-01-28
- 2026-04-08
- 2026-07-09
Trades before a print in Nurix Therapeutics, Inc. 0
- 6 days before the 2026-04-08 print — 2026-04-02 · S · Ring Christine · 8,148 shares
- 7 days before the 2026-07-09 print — 2026-07-02 · S · Ring Christine · 11,008 shares
- 8 days before the 2026-01-28 print — 2026-01-20 · S · Ring Christine · 3,760 shares
- 11 days before the 2025-01-13 print — 2025-01-02 · S · Ring Christine · 5,760 shares
- 14 days before the 2026-07-09 print — 2026-06-25 · S · Hansen Gwenn · 5,394 shares
- 14 days before the 2026-07-09 print — 2026-06-25 · S · Ring Christine · 28,935 shares
- 36 days before the 2025-04-08 print — 2025-03-03 · S · van Houte Hans · 5,125 shares
- 36 days before the 2025-04-08 print — 2025-03-03 · S · van Houte Hans · 700 shares
- 37 days before the 2026-04-08 print — 2026-03-02 · S · Ring Christine · 8,148 shares
- 37 days before the 2026-07-09 print — 2026-06-02 · S · Ring Christine · 8,148 shares
- 41 days before the 2026-01-28 print — 2025-12-18 · S · Ring Christine · 3,560 shares
- 41 days before the 2026-01-28 print — 2025-12-18 · S · Ring Christine · 200 shares
Interval to Nurix Therapeutics, Inc.’s next reported results date
How the interval and sources are counted →
- 0within 5 days
- 3within 10 days
- 6shortest, days
- 9no later print
- Ring Christine 2026-01-20 · S · 8 days before the 2026-01-28 print · Chief Legal Officer
- Ring Christine 2026-04-02 · S · 6 days before the 2026-04-08 print · Chief Legal Officer
- Ring Christine 2026-07-02 · S · 7 days before the 2026-07-09 print · Chief Legal Officer
Reported results dates on file
- 2025-01-13
- 2025-01-28
- 2025-04-08
- 2025-07-09
- 2025-10-09
- 2026-01-28
- 2026-04-08
- 2026-07-09
A proxy statement is on file for this company in the same window, which is where a company states its own trading policy.
Other companies with plan records
- BRISTOL MYERS SQUIBB CO 2
- FMC CORP 2
- ELI LILLY & Co 11
- ABEONA THERAPEUTICS INC. 7
- HEXCEL CORP /DE/ 2
- TEVA PHARMACEUTICAL INDUSTRIES LTD 37
- Lifevantage Corp 3
- IONIS PHARMACEUTICALS INC 86
- VERTEX PHARMACEUTICALS INC / MA 74
- ARROWHEAD PHARMACEUTICALS, INC. 23
Sources: SEC EDGAR full-text search and the SEC submissions API.
The address of this record
Nurix Therapeutics, Inc.’s insider trading plan record — 25 Form 4 statements in the 2025 filing year — is published at one address, this page. When you cite or link the record, use https://velarionrecords.com/plan10b5/issuer/0001549595.